Expert Advice from Dr. Alayna Newton
When considering the use of Photobiomodulation for the treatment of specific conditions, it is vital to seek guidance from a knowledgeable and experienced practitioner. A consultation with an expert photobiomodulation practitioner ensures that individual precautions and contraindications are thoroughly discussed and taken into account to allow for maximum treatment effects and the most comfortable experience.
​
Photobiomodulation operates on a principle known as the 'Biphasic Dose Response,' which emphasizes the importance of using the appropriate parameters of light to yield optimal benefits for the body. By working with a skilled provider, you can ensure that the correct light dosage and treatment protocols are tailored to your unique needs, maximizing the effectiveness of Photobiomodulation therapy.
​
Dr. Alayna Newton is equipped with extensive knowledge and experience in utilizing this modality, enabling her to assess your specific circumstances and develop a personalized treatment plan. Through a comprehensive consultation, we will address your concerns, provide thorough guidance, and support you in achieving the best possible outcomes from Photobiomodulation therapy.
By involving an Expert Photobiomodulation Practitioner in your treatment journey, you can have confidence in the comprehensive evaluation and thoughtful consideration given to your unique circumstances.
Prioritizing the involvement of a skilled practitioner in your Photobiomodulation journey is key to unlocking its full potential and ensuring a safe and effective treatment experience.
01
Mitochondrial Activation
Within cellular structures known as mitochondria lies the pivotal mechanism of red light therapy. Analogous to photosynthesis in plants, these organelles absorb light energy, facilitating the conversion into Adenosine Triphosphate (ATP), the primary source of cellular energy.
02
Adenosine Triphospate (ATP) Synthesis
Red light exposure initiates a cascade of molecular events within mitochondria, culminating in heightened ATP synthesis. This surge in ATP levels empowers cellular processes, promoting enhanced cellular function, repair, and replication.
03
Cellular Optimization
Increased ATP production translates to bolstered cellular vitality. Cells infused with greater energy reserves exhibit augmented performance, facilitating efficient repair mechanisms and cellular replication.
​
The upsurge in ATP production instigated by red light exposure initiates a spectrum of physiological responses. These encompass heightened collagen synthesis, augmented blood perfusion, and mitigated inflammation, collectively fostering comprehensive physiological enhancement and expediting healing processes.
PROMOTE CELLULAR HEALTH
IMPROVE CIRCULATION
-
Stimulates Body to produce ATP
-
Stimulates collagen production
-
Strengthens hair and improves skin elasticity
-
Promotes connective tissue health
-
Improves healing of scars and tissue repair
-
Dilates blood vessels for increased flow
-
Protects red blood cells and platelets
-
May stimulate the brain's pineal gland
IMPROVE RECOVERY
-
Accelerates muscle repair
-
Stimulates mitochondria and stem cells for faster recovery
SUPPORT IMMUNE SYSTEM
Your provider will Individualized your Treatment Plan
Red light therapy naturally stimulates your body’s own production of ATP (Adenosine Triphosphate), a key element in cellular regeneration.
REDUCE PAIN
-
Promotes healing to nervous system
-
Eases joint stiffness and soreness
-
Diminishes inflammation
-
Reduces muscle spasms and increases blood flow
REDUCE INFLAMMATION
-
Soothes sore muscles, joint pain, and arthritis
-
Eases symptoms associated with autoimmune diseases, spinal cord and traumatic brain injuries
Promising Preliminary Research
June 2021
Whole-organ transdermal photobiomodulation (PBM) of COVID-19: A 50-patient case study
The study highlights the potential of Photobiomodulation (PBM) as a therapeutic modality for the treatment of COVID-19 and related inflammatory diseases. PBM therapy, using nonionizing electromagnetic radiation, has shown benefits such as reduced tissue inflammation, improved circulation, decreased pain, and accelerated recovery. The study conducted on a non-randomized sample of COVID-19 patients demonstrated that PBM treatment resulted in full symptom recovery within three weeks for all 50 patients, with the majority recovering within four days. Acute symptoms, including improved breathing, reduced coughing, fever relief, sinus congestion alleviation, and eye inflammation reduction, were rapidly relieved with PBM therapy, typically requiring a single session.
The study suggests that PBM has the potential to be a non-pharmacological treatment option for COVID-19, offering advantages over pharmacological regimens without adverse side effects. Further research is needed to optimize treatment pro
​
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646787/pdf/JBIO-15-0.pdf
March 2021
Evaluation of Adjunctive Photobiomodulation (PBMT) for COVID-19 Pneumonia via Clinical Status and Pulmonary Severity Indices in a Preliminary Trial
This research paper explores the potential benefits of adjunctive Photobiomodulation Therapy (PBMT) in the treatment of COVID-19 pneumonia. The study highlights the cytokine storm and acute respiratory distress syndrome (ARDS) as initial hallmarks of COVID-19 and the need for effective treatment strategies. PBMT, also known as low-level laser therapy, uses non-ionizing, non-thermal light sources to reduce inflammation and stimulate healing. Experimental and animal models have shown that PBMT has anti-inflammatory effects and can modulate the immune response. The study conducted a small-scale clinical trial with a PBMT group and a control group and assessed patient outcomes using pulmonary severity indices.
The results showed that the PBMT group had significant improvements in pulmonary function, oxygenation, and chest X-ray findings compared to the control group. Additionally, none of the PBMT patients required ICU admission or mechanical ventilation, while 60% of the control group did. The study suggests that adjunctive PBMT may improve the clinical status of COVID-19 patients, reduce the need for ventilator support, and enhance the recovery process. Further research with larger sample sizes is recommended to confirm these findings and explore the potential of PBMT in COVID-19 treatment.
​
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989376/pdf/jir-14-965.pdf
Dec 2020
The Effectiveness of Photobiomudulation Therapy (PBMT) in COVID-19 Infection
The research study discusses the potential use of Photobiomodulation Therapy (PBMT), also known as cold laser therapy or low-level laser therapy (LLLT), in the treatment of patients with severe acute respiratory distress syndrome (ARDS) associated with COVID-19. The study highlights the severity of the disease caused by the SARS-CoV-2 virus and the wide range of symptoms it can present, from mild respiratory symptoms to acute respiratory distress syndrome and multi-organ dysfunction. The mortality rate in patients with ARDS is high, emphasizing the need for effective treatment strategies. The study explores the anti-inflammatory effects of PBMT and its potential role in improving respiratory symptoms in COVID-19 patients by reviewing published studies in this field.
The authors explain that PBMT involves the use of visible and near-infrared light to stimulate cellular functions and promote tissue healing. It has been used in various medical applications, including reducing pain, inflammation, and accelerating tissue repair. The study highlights experimental studies demonstrating the potential of PBMT in reducing lung inflammation, fibrosis, pneumonia, and acute respiratory disorders. Additionally, the antimicrobial effects of monochromatic blue light are discussed, suggesting its potential use in reducing secondary bacterial infections associated with respiratory viral infections like SARS-CoV-2.
The study emphasizes the need for further research and clinical trials to establish the efficacy of PBMT in treating COVID-19 and reducing lung inflammation and pneumonia associated with the disease. While there have been a few case reports demonstrating positive outcomes with PBMT in COVID-19 patients, more comprehensive studies are necessary to validate its effectiveness and establish proper treatment protocols.
​
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956025/pdf/jlms-11-S23.pdf